Niagen Bioscience, Inc. Common Stock NAGE Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $66.55M+2.7% | $64.79M+0.8% | $64.29M+6.3% | $60.47M+8.7% | $55.62M+24.5% | ||
| $13.07M+34.2% | $9.74M+14.5% | $8.51M-11.9% | $9.66M+36.9% | $7.05M-9.2% | ||
| $24.02M+17.6% | $20.42M+8.7% | $18.79M+30.4% | $14.41M+28.8% | $11.19M+21.7% | ||
| $105.12M+8.6% | $96.81M+3.4% | $93.62M+8.0% | $86.68M+13.7% | $76.22M+18.9% | ||
| $1.3M-1.9% | $1.32M-11.7% | $1.5M-8.1% | $1.63M-1.4% | $1.66M-3.7% | ||
| $5.49M-3.1% | $5.66M+2,201% | $246K-13.4% | $284K-11.8% | $322K-10.3% | ||
| $114.33M+7.4% | $106.41M+8.4% | $98.14M+7.2% | $91.53M+12.5% | $81.34M+19.1% | ||
| $13.28M+23.0% | $10.8M-15.3% | $12.74M-6.9% | $13.68M+28.7% | $10.63M+24.7% | ||
| $380K-4.8% | $399K+36.6% | $292K-3.6% | $303K+46.4% | $207K-66.1% | ||
| $22.82M+14.6% | $19.92M-12.3% | $22.71M+1.7% | $22.33M+7.2% | $20.84M+16.1% | ||
| $32M+7.1% | $29.87M+8.8% | $27.46M+0.5% | $27.33M+5.1% | $25.99M+17.2% | ||
| 150M0.0% | 150M0.0% | 150M0.0% | 150M0.0% | 150M+194,705% | ||
| -$158.21M+3.8% | -$164.53M+2.4% | -$168.66M+2.6% | -$173.24M+2.0% | -$176.85M+2.8% | ||
| $82.33M+7.6% | $76.53M+8.3% | $70.68M+10.1% | $64.2M+16.0% | $55.35M+20.1% | ||
| $114.33M+7.4% | $106.41M+8.4% | $98.14M+7.2% | $91.53M+12.5% | $81.34M+19.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Niagen Bioscience, Inc. Common Stock's total assets?
- Niagen Bioscience, Inc. Common Stock (NAGE) holds $114.3M in total assets, up 40.6% year over year.
- How much debt does Niagen Bioscience, Inc. Common Stock have?
- Niagen Bioscience, Inc. Common Stock carries $2.6M in total debt against $82.3M of shareholders' equity, a debt-to-equity ratio of 0.03.
- How much cash does Niagen Bioscience, Inc. Common Stock have?
- Niagen Bioscience, Inc. Common Stock holds $66.5M in cash and equivalents.
- Can Niagen Bioscience, Inc. Common Stock cover its short-term obligations?
- Its current ratio is 4.61 — current assets exceed current liabilities.
- Where does Niagen Bioscience, Inc. Common Stock's balance sheet data come from?
- Every line is extracted from Niagen Bioscience, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
